Table 2.
Multivariable analysis of factors associated with estimation of prostate volume using MRI or TRUS volume
| Covariate | MRI | TRUS | ||||
|---|---|---|---|---|---|---|
|
| ||||||
| Co-efficient | (95% CI) | p value | Co-efficient | (95% CI) | p value | |
| BMI | 0.105 | (−0.004–0.215) | 0.060 | 0.072 | (−0.063–0.207) | 0.296 |
| Height | 0.098 | (−0.091–0.287) | 0.310 | −0.078 | (−0.317–0.162) | 0.523 |
| Weight | 0.010 | (−0.077–0.096) | 0.830 | 0.019 | (−0.089–0.128) | 0.729 |
| Median lobe | −8.123 | (−12.766–−3.840) | 0.001 | −8.150 | (−13.880– −2.421) | 0.005 |
| pT3 (vs. pT2) | −1.789 | (−4.082–0.504) | 0.126 | −2.169 | (−4.989–0.650) | 0.131 |
| Gleason sum (6 vs. 7 vs. 8–10) | 1.157 | (−4.082–0.504) | 0.084 | 0.725 | (−0.895–2.344) | 0.380 |
| Preoperative PSA | 0.088 | (−0.043–0.218) | 0.187 | 0.115 | (−0.049–0.279) | 0.168 |
| Year of MRI/TRUS | 0.465 | (−0.052–0.981) | 0.078 | 0.062 | (−0.574–0.699) | 0.847 |
BMI: body mass index; CI: confidence interval; MRI: magnetic resonance imaging; PSA: prostate-specific antigen; TRUS: transrectal ultrasound.